141 related articles for article (PubMed ID: 12107672)
21. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
McKinnon PS; Sorensen SV; Liu LZ; Itani KM
Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
[TBL] [Abstract][Full Text] [Related]
22. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.
Gallagher JC; Perez ME; Marino EA; LoCastro LG; Abrardo LA; MacDougall C
Pharmacotherapy; 2009 Jul; 29(7):792-9. PubMed ID: 19558253
[TBL] [Abstract][Full Text] [Related]
23. At-risk drinkers are at higher risk to acquire a bacterial infection during an intensive care unit stay than abstinent or moderate drinkers.
Gacouin A; Legay F; Camus C; Volatron AC; Barbarot N; Donnio PY; Thomas R; Le Tulzo Y
Crit Care Med; 2008 Jun; 36(6):1735-41. PubMed ID: 18520640
[TBL] [Abstract][Full Text] [Related]
24. Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures.
Hayden MK; Bonten MJ; Blom DW; Lyle EA; van de Vijver DA; Weinstein RA
Clin Infect Dis; 2006 Jun; 42(11):1552-60. PubMed ID: 16652312
[TBL] [Abstract][Full Text] [Related]
25. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections.
Blot SI; Depuydt P; Annemans L; Benoit D; Hoste E; De Waele JJ; Decruyenaere J; Vogelaers D; Colardyn F; Vandewoude KH
Clin Infect Dis; 2005 Dec; 41(11):1591-8. PubMed ID: 16267731
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre.
Shaikh ZH; Osting CA; Hanna HA; Arbuckle RB; Tarr JJ; Raad II
J Hosp Infect; 2002 May; 51(1):52-8. PubMed ID: 12009821
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies.
Furtado GH; Mendes RE; Pignatari AC; Wey SB; Medeiros EA
Am J Infect Control; 2006 Sep; 34(7):447-51. PubMed ID: 16945692
[TBL] [Abstract][Full Text] [Related]
28. Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units.
Perencevich EN; Fisman DN; Lipsitch M; Harris AD; Morris JG; Smith DL
Clin Infect Dis; 2004 Apr; 38(8):1108-15. PubMed ID: 15095215
[TBL] [Abstract][Full Text] [Related]
29. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
Shorr AF; Combes A; Kollef MH; Chastre J
Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
[TBL] [Abstract][Full Text] [Related]
30. Risk of acquiring antibiotic-resistant bacteria from prior room occupants.
Huang SS; Datta R; Platt R
Arch Intern Med; 2006 Oct; 166(18):1945-51. PubMed ID: 17030826
[TBL] [Abstract][Full Text] [Related]
31. The impact of time to tracheostomy on mechanical ventilation duration, length of stay, and mortality in intensive care unit patients.
Arabi YM; Alhashemi JA; Tamim HM; Esteban A; Haddad SH; Dawood A; Shirawi N; Alshimemeri AA
J Crit Care; 2009 Sep; 24(3):435-40. PubMed ID: 19327302
[TBL] [Abstract][Full Text] [Related]
32. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Horowitz HW; Wormser GP
Infect Control Hosp Epidemiol; 2001 Jul; 22(7):437-42. PubMed ID: 11583213
[TBL] [Abstract][Full Text] [Related]
33. Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.
Chavers LS; Moser SA; Funkhouser E; Benjamin WH; Chavers P; Stamm AM; Waites KB
Microb Drug Resist; 2003; 9 Suppl 1():S69-77. PubMed ID: 14633370
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center.
Lodise TP; McKinnon PS; Tam VH; Rybak MJ
Clin Infect Dis; 2002 Apr; 34(7):922-9. PubMed ID: 11880957
[TBL] [Abstract][Full Text] [Related]
35. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.
DiazGranados CA; Jernigan JA
J Infect Dis; 2005 Feb; 191(4):588-95. PubMed ID: 15655783
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for rectal colonization with vancomycin-resistant enterococci in Shiraz, Iran.
Askarian M; Afkhamzadeh R; Monabbati A; Daxboeck F; Assadian O
Int J Infect Dis; 2008 Mar; 12(2):171-5. PubMed ID: 17855141
[TBL] [Abstract][Full Text] [Related]
37. The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients.
Bhorade SM; Christenson J; Pohlman AS; Arnow PM; Hall JB
Chest; 1999 Apr; 115(4):1085-91. PubMed ID: 10208212
[TBL] [Abstract][Full Text] [Related]
38. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
39. Primary sepsis in a university hospital in northern Sweden: a retrospective study.
Jacobson S; Johansson G; Winsö O
Acta Anaesthesiol Scand; 2004 Sep; 48(8):960-7. PubMed ID: 15315612
[TBL] [Abstract][Full Text] [Related]
40. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
Peel T; Cheng AC; Spelman T; Huysmans M; Spelman D
Clin Microbiol Infect; 2012 Apr; 18(4):388-94. PubMed ID: 21848977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
